Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Rademaker

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
The Australasian Journal of Dermatology|March 31, 2021
SARS-CoV-2 (COVID-19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology GroupCharlie Wang, Marius Rademaker, Bruce Tate, et al.
The Australasian Journal of Dermatology|December 26, 2023
Bridging AI development with clinical relevance-A scoping review of skin cancer models since CLEAR Derm. Where to next?Eugene Tan, Minh Tran, Marius Rademaker, et al.
Narra J|March 7, 2024
Global research profile on monkeypox-related literature (1962-2022): A bibliometric analysisFajar Sofyantoro, Hendrix I Kusuma, Sandro Vento, et al.
Journal of the American Academy of Dermatology|December 7, 2006
Cavitary pyoderma gangrenosum treated with local infusion of corticosteroidBen Tallon, Marius Rademaker, Grant Parkinson, et al.
The Australasian Journal of Dermatology|October 25, 2007
Extremely high levels of melanoma in Tauranga, New Zealand: possible causes and comparisons with Australia and the northern hemispherePaul Jm Salmon, Weng Chen Chan, Jenny Griffin, et al.
The Australasian Journal of Dermatology|August 21, 2020
Guidance on infection control and plume management with Laser and Energy-Based Devices taking into consideration COVID-19John R Sullivan, Marius Rademaker, Greg Goodman, et al.
Current Medical Research and Opinion|June 25, 2019
VITALITY: impact of adalimumab on health and disability outcomes in patients with Crohn's disease, rheumatoid arthritis, or psoriasis treated in clinical practice in New ZealandRichard B Gearry, Christopher Frampton, Stephen Inns, et al.
The New Zealand Medical Journal|June 29, 2010
Medical image. Systemic lupus erythematosus (SLE) in a paediatric unitTilak de Almeida, Rachel Davey, Kamal Solanki, et al.
The Australasian Journal of Dermatology|March 24, 2022
Bullous pemphigoid: Its incidence, mortality and clinical outcome in New ZealandJenny G Chung, Rajan Ramji, Christin Coomarasamy, et al.
The Australasian Journal of Dermatology|February 18, 2020
E-referrals and teledermatoscopy grading for melanoma: a successful model of careMichael Sunderland, Rebecca Teague, Katherine Gale, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
The Australasian Journal of Dermatology|March 31, 2021
SARS-CoV-2 (COVID-19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology GroupCharlie Wang, Marius Rademaker, Bruce Tate, et al.
The Australasian Journal of Dermatology|December 26, 2023
Bridging AI development with clinical relevance-A scoping review of skin cancer models since CLEAR Derm. Where to next?Eugene Tan, Minh Tran, Marius Rademaker, et al.
Narra J|March 7, 2024
Global research profile on monkeypox-related literature (1962-2022): A bibliometric analysisFajar Sofyantoro, Hendrix I Kusuma, Sandro Vento, et al.
Journal of the American Academy of Dermatology|December 7, 2006
Cavitary pyoderma gangrenosum treated with local infusion of corticosteroidBen Tallon, Marius Rademaker, Grant Parkinson, et al.
The Australasian Journal of Dermatology|October 25, 2007
Extremely high levels of melanoma in Tauranga, New Zealand: possible causes and comparisons with Australia and the northern hemispherePaul Jm Salmon, Weng Chen Chan, Jenny Griffin, et al.
The Australasian Journal of Dermatology|August 21, 2020
Guidance on infection control and plume management with Laser and Energy-Based Devices taking into consideration COVID-19John R Sullivan, Marius Rademaker, Greg Goodman, et al.
Current Medical Research and Opinion|June 25, 2019
VITALITY: impact of adalimumab on health and disability outcomes in patients with Crohn's disease, rheumatoid arthritis, or psoriasis treated in clinical practice in New ZealandRichard B Gearry, Christopher Frampton, Stephen Inns, et al.
The New Zealand Medical Journal|June 29, 2010
Medical image. Systemic lupus erythematosus (SLE) in a paediatric unitTilak de Almeida, Rachel Davey, Kamal Solanki, et al.
The Australasian Journal of Dermatology|March 24, 2022
Bullous pemphigoid: Its incidence, mortality and clinical outcome in New ZealandJenny G Chung, Rajan Ramji, Christin Coomarasamy, et al.
The Australasian Journal of Dermatology|February 18, 2020
E-referrals and teledermatoscopy grading for melanoma: a successful model of careMichael Sunderland, Rebecca Teague, Katherine Gale, et al.
Pageof 11